220 related articles for article (PubMed ID: 14752879)
61. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
62. PRETEXT II-III multifocal hepatoblastoma: significance of resection of satellite lesions irrespective of their disappearance after chemotherapy.
Qureshi SS; Bhagat M; Kembhavi S; Vora T; Ramadwar M; Talole S
Pediatr Surg Int; 2015 Jun; 31(6):573-9. PubMed ID: 25904441
[TBL] [Abstract][Full Text] [Related]
63. Guidelines for surgical treatment of hepatoblastoma in the modern era--recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).
Czauderna P; Otte JB; Aronson DC; Gauthier F; Mackinlay G; Roebuck D; Plaschkes J; Perilongo G;
Eur J Cancer; 2005 May; 41(7):1031-6. PubMed ID: 15862752
[TBL] [Abstract][Full Text] [Related]
64. Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach.
Srinivasan S; Prasad M; Parambil BC; Shrimal A; Gollamudi VRM; Subramani V; Ramadwar M; Khanna N; Baheti AD; Gala K; Patil V; Laskar S; Qureshi S; Chinnaswamy G
Pediatr Blood Cancer; 2023 Jul; 70(7):e30302. PubMed ID: 37046413
[TBL] [Abstract][Full Text] [Related]
65. Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
Kubota M; Yagi M; Kanada S; Yamazaki S; Tanaka S; Asami K; Ogawa A; Watanabe A; Iwabuchi H; Kaneko M; Saida Y
J Pediatr Surg; 2004 Dec; 39(12):1775-8. PubMed ID: 15616926
[TBL] [Abstract][Full Text] [Related]
66. Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study.
Watanabe K; Mori M; Hishiki T; Yokoi A; Ida K; Yano M; Fujimura J; Nogami Y; Iehara T; Hoshino K; Inoue T; Tanaka Y; Miyazaki O; Takimoto T; Yoshimura K; Hiyama E
Pediatr Blood Cancer; 2022 Feb; 69(2):e29389. PubMed ID: 34606680
[TBL] [Abstract][Full Text] [Related]
67. Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.
Illiano M; Colinard M; Taque S; Mallon B; Larue C; Laithier V; Vérité-Goulard C; Sudour-Bonnange H; Faure-Conter C; Coze C; Aerts I; De Maricourt CD; Paillard C; Branchereau S; Brugières L; Fresneau B
Hepatol Int; 2022 Feb; 16(1):125-134. PubMed ID: 34506008
[TBL] [Abstract][Full Text] [Related]
68. Hepatoblastoma: an oncological review.
Roebuck DJ; Perilongo G
Pediatr Radiol; 2006 Mar; 36(3):183-6. PubMed ID: 16404556
[TBL] [Abstract][Full Text] [Related]
69. Avoiding liver transplantation in post-treatment extent of disease III and IV hepatoblastoma.
El-Gendi A; Fadel S; El-Shafei M; Shawky A
Pediatr Int; 2018 Sep; 60(9):862-868. PubMed ID: 29906299
[TBL] [Abstract][Full Text] [Related]
70. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
[TBL] [Abstract][Full Text] [Related]
71. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
72. SIOPEL trials using preoperative chemotherapy in hepatoblastoma.
Perilongo G; Shafford E; Plaschkes J;
Lancet Oncol; 2000 Oct; 1():94-100. PubMed ID: 11905674
[TBL] [Abstract][Full Text] [Related]
73. Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
Kusano T; Aoki H; Kinjo T; Miyazato H; Shimoji H; Isa T; Muto Y
J Hepatobiliary Pancreat Surg; 2000; 7(4):410-6. PubMed ID: 11180863
[TBL] [Abstract][Full Text] [Related]
74. Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.
Leal-Leal CA; Imaz-Olguín V; Robles-Castro J; Shalkow-Klincovstein J; Palacios-Acosta JM
Ann Hepatol; 2010; 9(1):75-9. PubMed ID: 20308725
[TBL] [Abstract][Full Text] [Related]
75. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
Liu G; Liu B; Li K; Dong K; Xiao X
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):119-23. PubMed ID: 25876687
[TBL] [Abstract][Full Text] [Related]
76. [A follow-up report of childhood hepatoblastoma from 74 cases in a single center].
Wang TY; Pan C; Tang JY; Ye QD; Zhou M; Gao YJ; Hu WT
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):364-368. PubMed ID: 28482388
[No Abstract] [Full Text] [Related]
77. Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
Nguyen R; McCarville MB; Sykes A; Mao S; Wu J; Langham MR; Furman WL
Int J Clin Oncol; 2018 Oct; 23(5):900-907. PubMed ID: 29744604
[TBL] [Abstract][Full Text] [Related]
78. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis.
Nijstad AL; van Eijkelenburg NKA; Kraal KCJM; Meijs MJM; de Kanter CTMM; Lilien MR; Huitema ADR
Cancer Chemother Pharmacol; 2020 Sep; 86(3):445-449. PubMed ID: 32816154
[TBL] [Abstract][Full Text] [Related]
79. Neoadjuvant chemotherapy before surgery of hepatoblastoma.
Udupa KV; Navadgi SM; Mullerpatan P; Chhabra D; Shah RC; Jagannath P
Indian J Pediatr; 2006 Aug; 73(8):735-7. PubMed ID: 16936371
[TBL] [Abstract][Full Text] [Related]
80. Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
Brown J; Perilongo G; Shafford E; Keeling J; Pritchard J; Brock P; Dicks-Mireaux C; Phillips A; Vos A; Plaschkes J
Eur J Cancer; 2000 Jul; 36(11):1418-25. PubMed ID: 10899656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
